12/02/2026
During Senate Economics Legislation Committee hearings, Senator Matthew Canavan raised the joint AMPS–NPAA complaint with the ACCC, questioning the regulator about its handling of concerns regarding potentially misleading health-related fundraising claims.
The complaint relates to representations made to the public about medical interventions for children, where the evidence base, risks, and regulatory safeguards remain contested.
When vulnerable children are involved, professional claims must be accurate, evidence-based, and subject to proper scrutiny.
This is a matter of consumer law, patient safety, and regulatory responsibility, not ideology.